OpenDNA

OpenDNA
AI platform for genetically personalized medicine of chronic multi-gene diseases, focusing on hypertension.
About
What does OpenDNA do?
OpenDNA is developing an artificial intelligence platform designed for genetically personalized medicine, specifically targeting chronic multi-gene diseases. Their platform aims to empower physicians to prescribe the most genetically suitable treatments to patients at the point of care. The company's initial focus is on hypertension, also known as the silent killer.
Where is OpenDNA headquartered?
OpenDNA is headquartered in San Diego, United States.
When was OpenDNA founded?
OpenDNA was founded in 2017.
What industry does OpenDNA operate in?
OpenDNA operates in Hypertension, Healthcare, Point of care, Genomics, HealthTech, MedTech.
Eccoscience is a startup focused on developing AI-powered solutions for scientific research and discovery.
Automated ACMG classification, phenotype matching, and clinical reporting for genetic diagnostics, transforming raw genomic data into actionable clinical insights.
AI-powered platform for personalized health and longevity.
Explore cutting-edge bio technology solutions with AI, launching soon.
AI-powered platform accelerating biological research and drug discovery.
Proprietary nutritional analysis systems for wellbeing, sports, and grocery retail.
Apimedtech is developing a novel platform for personalized medicine, leveraging AI and advanced analytics to improve patient outcomes.
Bioexplorer is a platform that leverages AI to help users explore and understand biological data, including genes, proteins, and diseases.
An entrant is a company tagged Genomics whose domain was first registered in the window, counted from registry records in the StartupHub directory. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.